tiprankstipranks
Trending News
More News >
AbbVie (GB:0QCV)
LSE:0QCV
UK Market
Advertisement

AbbVie (0QCV) Technical Analysis

Compare
11 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbbVie’s (0QCV) Moving Averages Convergence Divergence (MACD) indicator is 3.85, suggesting AbbVie is a Buy.
AbbVie’s (0QCV) 20-Day exponential moving average is 226.36, while AbbVie’s (0QCV) share price is $229.35, making it a Buy.
AbbVie’s (0QCV) 50-Day exponential moving average is 217.21, while AbbVie’s (0QCV) share price is $229.35, making it a Buy.

AbbVie (0QCV) Pivot Points

Oct 21, 2025, 02:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
223.46
224.49
225.81
226.84
228.16
229.19
230.51
Fibonacci
224.49
225.38
225.94
226.84
227.73
228.29
229.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (0QCV) Moving Averages

Oct 21, 2025, 02:30 AM
Period
Simple
Exponential
MA5
228.50Buy
228.58Buy
MA10
229.10Buy
228.61Buy
MA20
227.33Buy
226.36Buy
MA50
216.19Buy
217.21Buy
MA100
201.74Buy
207.10Buy
MA200
194.09Buy
197.23Buy
AbbVie’s (0QCV) 10-Day exponential moving average is 228.61, while AbbVie’s (0QCV) share price is $229.35, making it a Buy.
AbbVie’s (0QCV) 100-Day exponential moving average is 207.10, while AbbVie’s (0QCV) share price is $229.35, making it a Buy.
AbbVie’s (0QCV) stock price is $229.35 and AbbVie’s (0QCV) 50-day simple moving average is 216.19, creating a Buy signal.
AbbVie’s (0QCV) stock price is $229.35 and AbbVie’s (0QCV) 100-day simple moving average is 201.74, creating a Buy signal.
AbbVie’s (0QCV) stock price is $229.35 and AbbVie’s (0QCV) 200-day simple moving average is 194.09, creating a Buy signal.

AbbVie (0QCV) Technical Indicators

Oct 21, 2025, 02:30 AM
Name
Value
Implied Action
RSI (14)
58.26
Neutral
STOCH (9,6)
31.44
Neutral
STOCHRSI (14)
30.46
Neutral
MACD (12,26)
3.85
Buy
ADX (14)
42.05
Neutral
Williams %R
-68.88
Buy
CCI (14)
2.86
Neutral
ATR (14)
5.10
-
Ultimate Oscillator
40.83
Neutral
ROC
4.66
Buy
AbbVie’s (0QCV) Relative Strength Index (RSI) is 58.26, creating a Neutral signal.
AbbVie’s (0QCV) Trend Strength Indicator (ADX) is 42.05, creating a Neutral signal.
AbbVie’s (0QCV) Commodity Channel Index (CCI) is 2.86, creating a Neutral signal.
AbbVie’s (0QCV) Price Rate of Change (ROC) is 4.66, creating a Buy signal.

FAQ

Is 0QCV a Buy, Hold, or Sell?
Based on 0QCV’s technical indicators, 0QCV is a Strong Buy.
    What is 0QCV’s RSI (14)?
    0QCV’s RSI (14) is 58.26, which suggests 0QCV is a Neutral.
      What is 0QCV’s MACD?
      0QCV’s MACD is 3.85, which suggests 0QCV is a Buy.
        What is 0QCV’s 5-day moving average?
        0QCV’s 5-day moving average is 228.50, which suggests 0QCV is a Buy.
          What is 0QCV’s 20-day moving average?
          0QCV 20-day moving average is 227.33, which suggests 0QCV is a Buy.
            What is 0QCV’s 50-day moving average?
            0QCV’s 50-day moving average is 216.19, which suggests 0QCV is a Buy.
              What is 0QCV’s 200-day moving average?
              0QCV’s 200-day moving average is 194.09, which suggests 0QCV is a Buy.
                What is 0QCV’s Williams % R (14)?
                0QCV’s Williams % R (14) is -68.88, which suggests 0QCV is a Buy.
                  What is 0QCV’s CCI (14)?
                  0QCV’s CCI (14) is 2.86, which suggests 0QCV is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis